Could insulin eye drops save sight? stanford tests new glaucoma approach
NCT ID NCT05206877
Summary
This early-stage study is testing whether applying insulin directly to the eye as a drop is safe for people with glaucoma and similar optic nerve conditions. Researchers will enroll 52 participants to use the drops for 1-2 months and closely monitor for any side effects. They will also check if the treatment helps preserve vision by measuring changes in the retina and visual field.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Byers Eye Institute at Stanford University
RECRUITINGPalo Alto, California, 94303, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.